Regulation of Mucosal Inflammation by Th17 Subsets

$210,464P01FY2013DKNIH

University Of California, San Diego, La Jolla CA

Investigators

Linked publications & trials

Paper 27593154 Paper 27325418 Paper 27187615 Paper 26467188 Paper 26457610 Paper 26071205 Paper 25526314 Paper 25269705 Paper 25227984 Paper 25083990 Paper 24938743 Paper 24848114 Paper 24820073 Paper 24735923 Paper 24592899 Paper 24577114 Paper 24566625 Paper 24392888 Paper 24222690 Paper 24101497 Paper 24048169 Paper 23772033 Paper 23695512 Paper 23403423 Paper 23325885 Paper 23209324 Paper 23034650 Paper 22893683 Paper 22496368 Paper 22475534 Paper 22326954 Paper 22222875 Paper 22167182 Paper 22001876 Paper 21900533 Paper 21825286 Paper 21723868 Paper 21213148 Paper 21187438 Paper 21115691 Paper 21108592 Paper 21075147 Paper 20570699 Paper 20479237 Paper 20473309 Paper 20159620 Paper 20157112 Paper 20051628 Paper 20040863 Paper 19890270 Paper 19675161 Paper 19528876 Paper 19209676 Paper 18815378 Paper 18453602 Paper 18359106 Paper 18301258 Paper 18289546 Paper 18270590 Paper 18248436 Paper 18026955 Paper 18003900 Paper 17964578 Paper 17942668 Paper 17911629 Paper 17803913 Paper 17513563 Paper 17268238 Paper 17204341 Paper 17183673 Paper 17133081 Paper 17128265 Paper 17087937 Paper 17087935 Paper 17057215 Paper 17057211 Paper 17057188 Paper 17056558 Paper 16987516 Paper 16872373 Paper 16818780 Paper 16670522 Paper 16611235 Paper 16552082 Paper 16530515 Paper 16462163 Paper 16310259 Paper 15996766 Paper 15963781 Paper 15928914 Paper 15907557 Paper 15850703 Paper 15845488 Paper 15814717 Paper 15765149 Paper 15711205 Paper 15692052 Paper 15483227 Paper 15478797 Paper 15294155

Abstract

T helper (Th) cells in lymphoid tissues, depending on their location, develop into various Th subsets to regulate inflammation and defense. In the intestinal mucosa, their dominant phenotype is that of regulatory T (Treg) cells. Mucosal adjuvant, by overriding the tolerizing impact of mucosal Treg cells, are unique tools for dissecting immune regulation and inflammation. Our preliminary data indicate that cholera toxin (CT) and related compounds induce Thi7 cell differentiation via a cAMP-dependent and IL-6/TGF(3-independent pathway. To elucidate the mechanism by which adenylyl cyclase toxins and other luminal microbial products (TLR ligands) stimulate and modulate the mucosal microenvironment to promote effector Thi7 responses, we propose in Aim 1 to define how oral CT administration enhances Th17-promoting dendritic cells (DC) and suppresses Treg-promoting DC. We will explore the role of cAMP and retinoic acid in these processes, and characterize the subsequent Th cell response provoked by different MLN DC subsets. In Aim 2, we will characterize the phenotype, stability and lineage differentiation markers of CD4 T cells from in vitro- and in vivo-differentiated CT-induced Thi7 subsets, and evaluate the inflammatory/regulatory impact of orally delivered CT on the outcome of Thi7 cell-mediated colitis. Aim 3 will explore the role of CGRPP produced by CT-activated DC in a mucosal Thi7 response. Aim 4 will investigate the potential contributing role of TLR stimulation to CT-induced Thi7 differentiation. Dissecting the impact of CT and other cAMP-inducing compounds on mucosal DC maturation will significantly broaden our knowledge on the generation of mucosal Th responses. By dissecting the lineage stability of CT-induced mucosal Thi7 cells, their effector function, lineage commitment, trafficking and their interactions with other Th cells, we will increase our understanding of the regulation of inflammation and immunity at mucosal sites. The data generated in these studies may help to design new therapeutic approaches for mucosal inflammatory diseases and novel mucosal adjuvant.

View original record on NIH RePORTER →